(Q44353151)

2 December 2017

Diabetic endothelial dysfunction: effect of free radical scavenging in Type 2 diabetic patients (English)

1 reference

2 December 2017

Giancarlo De Mattia

1

1 reference

PubMed ID

12623166

2 December 2017

O Laurenti

series ordinal

2

1 reference

PubMed ID

12623166

2 December 2017

D Fava

series ordinal

3

1 reference

2 December 2017

1 March 2003

1 reference

Journal of Diabetes and its Complications

2 December 2017

1 reference

2 December 2017

17

1 reference

2 December 2017

2 Suppl

1 reference

2 December 2017

30-35

1 reference

L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Total radical-trapping antioxidant parameter in NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

A fluorescence-based method for measuring total plasma antioxidant capability

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Oxidative stress and diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

The vascular effects of L-Arginine in humans. The role of endogenous insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Nitric oxide availability in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: Clinical assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Nitric oxide: an endogenous modulator of leukocyte adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

In vitro and in vivo antioxidant properties of gliclazide.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Gliclazide: a general free radical scavenger

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Free radicals in diabetic endothelial cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

Correction of glycosylated oxyhemoglobin-induced impairment of endothelium-dependent vasodilatation by gliclazide

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900270-2

7 January 2021

10.1016/S1056-8727(02)00270-2

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

12623166